Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?

Etanercept for the Treatment of Hidradenitis Suppurativa

(2014) E Sotiriou et al.   ACTA DERMATO-VENEREOLOGICA

High circulating levels of S100A8/A9 complex (calprotectin) in male Japanese with abdominal adiposity and dysregulated expression of S100A8 and S100A9 in adipose tissues of obese mice

(2012) Ryohei Sekimoto et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin

(2012) Young Lee et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review

(2012) J.L. Blok et al.   BRITISH JOURNAL OF DERMATOLOGY

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments

(2012) Hessel H. van der Zee et al.   EXPERIMENTAL DERMATOLOGY

Novel insights into the role of S100A8/A9 in skin biology

(2012) Claus Kerkhoff et al.   EXPERIMENTAL DERMATOLOGY

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

(2012) Ren Mao et al.   INFLAMMATORY BOWEL DISEASES

Is calprotectin a marker of tobacco smoke related inflammation?: a pilot study in children

(2012) Nazan Cobanoglu et al.   INHALATION TOXICOLOGY

Alarmins: awaiting a clinical response

(2012) James K. Chan et al.   JOURNAL OF CLINICAL INVESTIGATION

Smoke-Induced Signal Molecules in Bone Marrow Cells from Altered Low-Density Lipoprotein Receptor-Related Protein 5 Mice

(2012) Danjun Ma et al.   JOURNAL OF PROTEOME RESEARCH

S100A8 and S100A9 in Cardiovascular Biology and Disease

(2011) Michelle M. Averill et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparative Evaluation of Serum Markers in Pulmonary Sarcoidosis

(2010) Seigo Miyoshi et al.   CHEST

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis

(2010) Gert Van Assche et al.   Journal of Crohns & Colitis

Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa

(2010) K. Wolk et al.   JOURNAL OF IMMUNOLOGY

Expression and Role of Myeloid-related Protein-14 in Clinical and Experimental Sepsis

(2009) Marieke A. D. van Zoelen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1β form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis

(2009) Michael Frosch et al.   ARTHRITIS AND RHEUMATISM

Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging

(2009) Łukasz Matusiak et al.   BIOMARKERS

Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity

(2009) K. Sartorius et al.   BRITISH JOURNAL OF DERMATOLOGY

Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study

(2009) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity

(2009) Florence Canoui-Poitrine et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hidradenitis suppurativa: A comprehensive review

(2009) Ali Alikhan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Calprotectin — A Novel Marker of Obesity

(2009) Ole Hartvig Mortensen et al.   PLoS One